Iranian Pediatric Hematology and Oncology Society
Iranian Journal of Blood and Cancer
2008-4595
2
3
2010
5
1
0
0
EN
Iranian Pediatric Hematology and Oncology Society
Iranian Journal of Blood and Cancer
2008-4595
2
3
2010
5
1
Myelofibrosis due to Secondary Hyperparathyroidism in a Case of Celiac Disease
0
0
EN
Myelofibrosis is reported in patents with primary hyperparathyroidism. It is also was reported in patents with sec-
ondary hyperparathyroidism due to end-stage renal disease or Vitamin D dependent rickets .We present a case of
celiac disease and osteomalacia which leads to secondary hyperparathyroidism and myelofibrosis.
Iranian Pediatric Hematology and Oncology Society
Iranian Journal of Blood and Cancer
2008-4595
2
3
2010
5
1
Congenital Leukemia: A Case Report
0
0
EN
Iranian Pediatric Hematology and Oncology Society
Iranian Journal of Blood and Cancer
2008-4595
2
3
2010
5
1
Restless Legs Syndrome Prevalence in Major Thalasemia Tabriz Children Hospital
0
0
EN
Iranian Pediatric Hematology and Oncology Society
Iranian Journal of Blood and Cancer
2008-4595
2
3
2010
5
1
Applying Totally Implantable Venous Access Devices (TIVAD) in Children: the First Iranian Experience
0
0
EN
Iranian Pediatric Hematology and Oncology Society
Iranian Journal of Blood and Cancer
2008-4595
2
3
2010
5
1
Density of Platelet GPIIb-IIIa and Bleeding Severity in Iranian Patients with Glanzmann’s Thrombasthenia
0
0
EN
Iranian Pediatric Hematology and Oncology Society
Iranian Journal of Blood and Cancer
2008-4595
2
3
2010
5
1
Pediatric Non Hodgkin’s Lymphomas
0
0
EN
Iranian Pediatric Hematology and Oncology Society
Iranian Journal of Blood and Cancer
2008-4595
2
3
2010
5
1
Patterns of Gelatinase-B Expression in Leukemic Cell Lines
0
0
EN
Iranian Pediatric Hematology and Oncology Society
Iranian Journal of Blood and Cancer
2008-4595
2
3
2010
5
1
Future
0
0
EN
Iranian Pediatric Hematology and Oncology Society
Iranian Journal of Blood and Cancer
2008-4595
2
3
2010
5
1
Intra articular Injection of Rifampin in Iranian Children with Haemophilic Arthropathy
123
127
EN
Background:Chronic synovitis is one of the most important complications in haemophilic patients. Rifampin is anantibiotic which its intra-articular injecion leads to destruction of the synovial membrane of haemophilic patientsmedically.Materials and Methods: Between September 2003 and November 2005, we administered intra-articular rifampinin ١۶ haemophilic joints of ٨ haemophilic patients.Results:Median age of our patients was 14.5 year-old. There were 11 knee joints and 5 elbow joints. Atier treatmentwe observed significant improvement in treated joints.Conclusion:This study reveals that intra-articular injection of rifampin may improve arthropathy in haemophilicpatients.